Zeyu Shuang
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating.
Journal: Cancer immunology, immunotherapy : CII
Published: January 10, 2023
A Prognostic Model for Breast Cancer Based on Cancer Incidence-Related DNA Methylation Pattern.
Journal: Frontiers in genetics
Published: November 13, 2021
Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC.
Journal: Frontiers in genetics
Published: June 24, 2021
Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 20, 2020
Bone metastasis pattern in initial metastatic breast cancer: a population-based study.
Journal: Cancer management and research
Published: February 23, 2018
Could local surgery improve survival in de novo stage IV breast cancer?
Journal: BMC cancer
Published: January 11, 2018
FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer.
Journal: Current cancer drug targets
Published: October 10, 2017
Score for the Survival Probability in Metastasis Breast Cancer: A Nomogram-Based Risk Assessment Model.
Journal: Cancer research and treatment
Published: September 18, 2017
Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 15, 2017
Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
Journal: BioMed research international
Published: July 03, 2017
Last Updated: 09/26/2026